Tech Company Financing Transactions

Gandeeva Therapeutics Funding Round

Leaps by Bayer, Lux Capital and Air Street Capital participated in a $40 million Series A venture round for Gandeeva Therapeutics. The financing was recorded on 2/5/2022.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

Undisclosed
Vancouver BC, V5K 1A1
Canada

Phone

Undisclosed

Website

www.gandeeva.com

Email Address

[email protected]

Overview

Our mission is to bring new treatment options to patients by revolutionizing drug discovery. For decades, scientists have known that understanding the language by which proteins are folded and function in the native context of the cell is fundamental to deciphering biology. Not surprisingly, altered protein structures are implicated in nearly every disease.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chairman

Doniel Kania

        

Chief Executive Officer

Sriram Subramaniam

        

Chief Financial Officer

David Karp

        

Vice President

Jason Crawford

        

VP - Human Resources

Donna Wong

        

Browse more venture capital transactions:

Prev: 2/5/2022: Turnip venture capital transaction
Next: 2/5/2022: Gupy venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on every notable VC transaction. All VC database entries on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary